APO Research
Talk to an analyst

APO RESEARCH · REPORT

LFA-based Cardiac

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

Selected research

Market Structure

Global LFA-based Cardiac Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchLFA-based Cardiac Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal LFA-based Cardiac Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal LFA-based Cardiac Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal LFA-based Cardiac Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal LFA-based Cardiac Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

Read the full market overview

Report Includes

This report provides an overview of the global LFA-based Cardiac market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of LFA-based Cardiac and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents LFA-based Cardiac revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the LFA-based Cardiac market size, projected growth trends, production technologies, key applications, and end-use industries.

LFA-based Cardiac Segment by Company

Roche

Abbott

Siemens

Danaher

Bio-Rad Laboratories

BioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox laboratories

Wondfo Biotech

LFA-based Cardiac Segment by Type

Troponin I

Troponin T

CK-MB

Myoglobin

Others

LFA-based Cardiac Segment by Application

Laboratory Testing

Point-of-care Testing

LFA-based Cardiac Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global LFA-based Cardiac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of LFA-based Cardiac and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of LFA-based Cardiac.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of LFA-based Cardiac in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global LFA-based Cardiac industry.

Chapter 3: Detailed analysis of LFA-based Cardiac companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, LFA-based Cardiacrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Troponin I Table 3. Key Players of Troponin T Table 4. Key Players of CK-MB Table 3. Key Players of Myoglobin Table 4. Key Players of Others Table 5. Global LFA-based Cardiac Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Laboratory Testing Table 7. Key Players of Point-of-care Testing Table 8. Global LFA-based Cardiac Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global LFA-based Cardiac Market Size by Region (2021-2026) & (US$ Million) Table 10. Global LFA-based Cardiac Market Share by Region (2021-2026) Table 11. Global LFA-based Cardiac Market Size by Region (2027-2032) & (US$ Million) Table 12. Global LFA-based Cardiac Market Share by Region (2027-2032) Table 13. LFA-based Cardiac Industry Trends Table 14. LFA-based Cardiac Industry Drivers Table 15. LFA-based Cardiac Industry Opportunities and Challenges Table 16. LFA-based Cardiac Industry Restraints Table 17. Global LFA-based Cardiac Revenue by Company (US$ Million) & (2021-2026) Table 18. Global LFA-based Cardiac Revenue Market Share by Company (2021-2026) Table 19. Global LFA-based Cardiac Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global LFA-based Cardiac Key Company Head Office and Area Served Table 21. Global LFA-based Cardiac Company, Product Type & Application Table 22. Global LFA-based Cardiac Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global LFA-based Cardiac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global LFA-based Cardiac Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 27. Global LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 28. Global LFA-based Cardiac Revenue Market Share by Type (2021-2026) Table 29. Global LFA-based Cardiac Revenue Market Share by Type (2027-2032) Table 30. Global LFA-based Cardiac Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 32. Global LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 33. Global LFA-based Cardiac Revenue Market Share by Application (2021-2026) Table 34. Global LFA-based Cardiac Revenue Market Share by Application (2027-2032) Table 35. Roche Company Information Table 36. Roche Business Overview Table 37. Roche LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Roche LFA-based Cardiac Product Portfolio Table 39. Roche Recent Development Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott LFA-based Cardiac Product Portfolio Table 44. Abbott Recent Development Table 45. Siemens Company Information Table 46. Siemens Business Overview Table 47. Siemens LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Siemens LFA-based Cardiac Product Portfolio Table 49. Siemens Recent Development Table 50. Danaher Company Information Table 51. Danaher Business Overview Table 52. Danaher LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Danaher LFA-based Cardiac Product Portfolio Table 54. Danaher Recent Development Table 55. Bio-Rad Laboratories Company Information Table 56. Bio-Rad Laboratories Business Overview Table 57. Bio-Rad Laboratories LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bio-Rad Laboratories LFA-based Cardiac Product Portfolio Table 59. Bio-Rad Laboratories Recent Development Table 60. BioMérieux Company Information Table 61. BioMérieux Business Overview Table 62. BioMérieux LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. BioMérieux LFA-based Cardiac Product Portfolio Table 64. BioMérieux Recent Development Table 65. Thermo Fisher Company Information Table 66. Thermo Fisher Business Overview Table 67. Thermo Fisher LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Thermo Fisher LFA-based Cardiac Product Portfolio Table 69. Thermo Fisher Recent Development Table 70. Ortho Clinical Diagnostics Company Information Table 71. Ortho Clinical Diagnostics Business Overview Table 72. Ortho Clinical Diagnostics LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ortho Clinical Diagnostics LFA-based Cardiac Product Portfolio Table 74. Ortho Clinical Diagnostics Recent Development Table 75. LSI Medience Corporation Company Information Table 76. LSI Medience Corporation Business Overview Table 77. LSI Medience Corporation LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. LSI Medience Corporation LFA-based Cardiac Product Portfolio Table 79. LSI Medience Corporation Recent Development Table 80. Randox laboratories Company Information Table 81. Randox laboratories Business Overview Table 82. Randox laboratories LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Randox laboratories LFA-based Cardiac Product Portfolio Table 84. Randox laboratories Recent Development Table 85. Wondfo Biotech Company Information Table 86. Wondfo Biotech Business Overview Table 87. Wondfo Biotech LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Wondfo Biotech LFA-based Cardiac Product Portfolio Table 89. Wondfo Biotech Recent Development Table 90. North America LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 91. North America LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 92. North America LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 93. North America LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 94. North America LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America LFA-based Cardiac Market Size by Country (2021-2026) Table 96. North America LFA-based Cardiac Market Size by Country (2027-2032) Table 97. Europe LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe LFA-based Cardiac Market Size by Country (2021-2026) Table 103. Europe LFA-based Cardiac Market Size by Country (2027-2032) Table 104. China LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 105. China LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 106. China LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 107. China LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia LFA-based Cardiac Market Size by Country (2021-2026) Table 114. Asia LFA-based Cardiac Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa LFA-based Cardiac Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa LFA-based Cardiac Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa LFA-based Cardiac Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa LFA-based Cardiac Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. LFA-based Cardiac Product Image Figure 2. Global LFA-based Cardiac Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global LFA-based Cardiac Market Share by Type: 2025 VS 2032 Figure 4. Troponin I Image Figure 5. Troponin T Image Figure 6. CK-MB Image Figure 7. Myoglobin Image Figure 8. Others Image Figure 9. Global LFA-based Cardiac Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global LFA-based Cardiac Market Share by Application: 2025 VS 2032 Figure 11. Laboratory Testing Image Figure 12. Point-of-care Testing Image Figure 13. Global LFA-based Cardiac Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 15. Global LFA-based Cardiac Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global LFA-based Cardiac Market Share by Players in 2025 Figure 18. Global Top 5 and 10 LFA-based Cardiac Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global LFA-based Cardiac Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global LFA-based Cardiac Revenue Market Share by Type (2021-2032) Figure 22. Global LFA-based Cardiac Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global LFA-based Cardiac Revenue Market Share by Application (2021-2032) Figure 24. North America LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 25. North America LFA-based Cardiac Market Share by Type (2021-2032) Figure 26. North America LFA-based Cardiac Market Share by Application (2021-2032) Figure 27. North America LFA-based Cardiac Market Share by Country (2021-2032) Figure 28. United States LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 29. Canada LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 30. Mexico LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 31. Europe LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 32. Europe LFA-based Cardiac Market Share by Type (2021-2032) Figure 33. Europe LFA-based Cardiac Market Share by Application (2021-2032) Figure 34. Europe LFA-based Cardiac Market Share by Country (2021-2032) Figure 35. Germany LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 36. France LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 37. U.K. LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 38. Italy LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 39. Russia LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 41. China LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 42. China LFA-based Cardiac Market Share by Type (2021-2032) Figure 43. China LFA-based Cardiac Market Share by Application (2021-2032) Figure 44. Asia LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 45. Asia LFA-based Cardiac Market Share by Type (2021-2032) Figure 46. Asia LFA-based Cardiac Market Share by Application (2021-2032) Figure 47. Asia LFA-based Cardiac Market Share by Country (2021-2032) Figure 48. Japan LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 49. South Korea LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 52. India LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 53. Australia LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa LFA-based Cardiac Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa LFA-based Cardiac Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa LFA-based Cardiac Market Share by Country (2021-2032) Figure 58. Brazil LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 59. South Africa LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 61. Turkey LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 62. Argentina LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 63. UAE LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 64. Egypt LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 65. Chile LFA-based Cardiac Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Troponin I
  • Troponin T
  • CK-MB
  • Myoglobin
  • Others
Applications
  • Laboratory Testing
  • Point-of-care Testing
Companies covered
  • Roche
  • Abbott
  • Siemens
  • Danaher
  • Bio-Rad Laboratories
  • BioMérieux
  • Thermo Fisher
  • Ortho Clinical Diagnostics
  • LSI Medience Corporation
  • Randox laboratories
  • Wondfo Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Troponin I
  5. 1.2.3 Troponin T
  6. 1.2.4 CK-MB
  7. 1.2.5 Myoglobin
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global LFA-based Cardiac Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Laboratory Testing
  12. 1.3.3 Point-of-care Testing
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global LFA-based Cardiac Growth Trends by Region
  15. 1.5.1 Global LFA-based Cardiac Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 LFA-based Cardiac Market Size by Region (2021-2026)
  17. 1.5.3 LFA-based Cardiac Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global LFA-based Cardiac Market Dynamics
  1. 2.1 LFA-based Cardiac Industry Trends
  2. 2.2 LFA-based Cardiac Industry Drivers
  3. 2.3 LFA-based Cardiac Industry Opportunities and Challenges
  4. 2.4 LFA-based Cardiac Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global LFA-based Cardiac Revenue by Company (2021-2026)
  2. 3.2 Global LFA-based Cardiac Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global LFA-based Cardiac Key Company Head office and Area Served
  4. 3.4 Global LFA-based Cardiac Company, Product Type & Application
  5. 3.5 Global LFA-based Cardiac Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global LFA-based Cardiac Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 LFA-based Cardiac Players Market Share by Revenue in 2025
  9. 3.6.3 2025 LFA-based Cardiac Tier 1, Tier 2, and Tier 3
4 LFA-based Cardiac Market by Type
  1. 4.1 Global LFA-based Cardiac Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global LFA-based Cardiac Market Size by Type (2021-2032)
  3. 4.3 Global LFA-based Cardiac Market Size Share by Type (2021-2032)
5 LFA-based Cardiac Market by Application
  1. 5.1 Global LFA-based Cardiac Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global LFA-based Cardiac Market Size by Application (2021-2032)
  3. 5.3 Global LFA-based Cardiac Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche LFA-based Cardiac Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott LFA-based Cardiac Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 Siemens
  14. 6.3.1 Siemens Company Information
  15. 6.3.2 Siemens Business Overview
  16. 6.3.3 Siemens LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Siemens LFA-based Cardiac Product Portfolio
  18. 6.3.5 Siemens Recent Developments
  19. 6.4 Danaher
  20. 6.4.1 Danaher Company Information
  21. 6.4.2 Danaher Business Overview
  22. 6.4.3 Danaher LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Danaher LFA-based Cardiac Product Portfolio
  24. 6.4.5 Danaher Recent Developments
  25. 6.5 Bio-Rad Laboratories
  26. 6.5.1 Bio-Rad Laboratories Company Information
  27. 6.5.2 Bio-Rad Laboratories Business Overview
  28. 6.5.3 Bio-Rad Laboratories LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bio-Rad Laboratories LFA-based Cardiac Product Portfolio
  30. 6.5.5 Bio-Rad Laboratories Recent Developments
  31. 6.6 BioMérieux
  32. 6.6.1 BioMérieux Company Information
  33. 6.6.2 BioMérieux Business Overview
  34. 6.6.3 BioMérieux LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 BioMérieux LFA-based Cardiac Product Portfolio
  36. 6.6.5 BioMérieux Recent Developments
  37. 6.7 Thermo Fisher
  38. 6.7.1 Thermo Fisher Company Information
  39. 6.7.2 Thermo Fisher Business Overview
  40. 6.7.3 Thermo Fisher LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thermo Fisher LFA-based Cardiac Product Portfolio
  42. 6.7.5 Thermo Fisher Recent Developments
  43. 6.8 Ortho Clinical Diagnostics
  44. 6.8.1 Ortho Clinical Diagnostics Company Information
  45. 6.8.2 Ortho Clinical Diagnostics Business Overview
  46. 6.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Product Portfolio
  48. 6.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 6.9 LSI Medience Corporation
  50. 6.9.1 LSI Medience Corporation Company Information
  51. 6.9.2 LSI Medience Corporation Business Overview
  52. 6.9.3 LSI Medience Corporation LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 LSI Medience Corporation LFA-based Cardiac Product Portfolio
  54. 6.9.5 LSI Medience Corporation Recent Developments
  55. 6.10 Randox laboratories
  56. 6.10.1 Randox laboratories Company Information
  57. 6.10.2 Randox laboratories Business Overview
  58. 6.10.3 Randox laboratories LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Randox laboratories LFA-based Cardiac Product Portfolio
  60. 6.10.5 Randox laboratories Recent Developments
  61. 6.11 Wondfo Biotech
  62. 6.11.1 Wondfo Biotech Company Information
  63. 6.11.2 Wondfo Biotech Business Overview
  64. 6.11.3 Wondfo Biotech LFA-based Cardiac Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Wondfo Biotech LFA-based Cardiac Product Portfolio
  66. 6.11.5 Wondfo Biotech Recent Developments
7 North America
  1. 7.1 North America LFA-based Cardiac Market Size (2021-2032)
  2. 7.2 North America LFA-based Cardiac Market Size by Type
  3. 7.2.1 North America LFA-based Cardiac Market Size by Type (2021-2026)
  4. 7.2.2 North America LFA-based Cardiac Market Size by Type (2027-2032)
  5. 7.2.3 North America LFA-based Cardiac Market Share by Type (2021-2032)
  6. 7.3 North America LFA-based Cardiac Market Size by Application
  7. 7.3.1 North America LFA-based Cardiac Market Size by Application (2021-2026)
  8. 7.3.2 North America LFA-based Cardiac Market Size by Application (2027-2032)
  9. 7.3.3 North America LFA-based Cardiac Market Share by Application (2021-2032)
  10. 7.4 North America LFA-based Cardiac Market Size by Country
  11. 7.4.1 North America LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America LFA-based Cardiac Market Size by Country (2021-2026)
  13. 7.4.3 North America LFA-based Cardiac Market Size by Country (2027-2032)
  14. 7.4.4 North America LFA-based Cardiac Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe LFA-based Cardiac Market Size (2021-2032)
  2. 8.2 Europe LFA-based Cardiac Market Size by Type
  3. 8.2.1 Europe LFA-based Cardiac Market Size by Type (2021-2026)
  4. 8.2.2 Europe LFA-based Cardiac Market Size by Type (2027-2032)
  5. 8.2.3 Europe LFA-based Cardiac Market Share by Type (2021-2032)
  6. 8.3 Europe LFA-based Cardiac Market Size by Application
  7. 8.3.1 Europe LFA-based Cardiac Market Size by Application (2021-2026)
  8. 8.3.2 Europe LFA-based Cardiac Market Size by Application (2027-2032)
  9. 8.3.3 Europe LFA-based Cardiac Market Share by Application (2021-2032)
  10. 8.4 Europe LFA-based Cardiac Market Size by Country
  11. 8.4.1 Europe LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe LFA-based Cardiac Market Size by Country (2021-2026)
  13. 8.4.3 Europe LFA-based Cardiac Market Size by Country (2027-2032)
  14. 8.4.4 Europe LFA-based Cardiac Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China LFA-based Cardiac Market Size (2021-2032)
  2. 9.2 China LFA-based Cardiac Market Size by Type
  3. 9.2.1 China LFA-based Cardiac Market Size by Type (2021-2026)
  4. 9.2.2 China LFA-based Cardiac Market Size by Type (2027-2032)
  5. 9.2.3 China LFA-based Cardiac Market Share by Type (2021-2032)
  6. 9.3 China LFA-based Cardiac Market Size by Application
  7. 9.3.1 China LFA-based Cardiac Market Size by Application (2021-2026)
  8. 9.3.2 China LFA-based Cardiac Market Size by Application (2027-2032)
  9. 9.3.3 China LFA-based Cardiac Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia LFA-based Cardiac Market Size (2021-2032)
  2. 10.2 Asia LFA-based Cardiac Market Size by Type
  3. 10.2.1 Asia LFA-based Cardiac Market Size by Type (2021-2026)
  4. 10.2.2 Asia LFA-based Cardiac Market Size by Type (2027-2032)
  5. 10.2.3 Asia LFA-based Cardiac Market Share by Type (2021-2032)
  6. 10.3 Asia LFA-based Cardiac Market Size by Application
  7. 10.3.1 Asia LFA-based Cardiac Market Size by Application (2021-2026)
  8. 10.3.2 Asia LFA-based Cardiac Market Size by Application (2027-2032)
  9. 10.3.3 Asia LFA-based Cardiac Market Share by Application (2021-2032)
  10. 10.4 Asia LFA-based Cardiac Market Size by Country
  11. 10.4.1 Asia LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia LFA-based Cardiac Market Size by Country (2021-2026)
  13. 10.4.3 Asia LFA-based Cardiac Market Size by Country (2027-2032)
  14. 10.4.4 Asia LFA-based Cardiac Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa LFA-based Cardiac Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa LFA-based Cardiac Market Size by Type
  3. 11.2.1 South America, Middle East & Africa LFA-based Cardiac Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa LFA-based Cardiac Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa LFA-based Cardiac Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa LFA-based Cardiac Market Size by Application
  7. 11.3.1 South America, Middle East & Africa LFA-based Cardiac Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa LFA-based Cardiac Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa LFA-based Cardiac Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa LFA-based Cardiac Market Size by Country
  11. 11.4.1 South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa LFA-based Cardiac Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa LFA-based Cardiac Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst